December 25, 2023 -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), today announced the U.S. Food and Drug Administration (FDA) has approved the new drug application (NDA) for ZORYVE (roflumilast) topical foam, 0.3% for t……
Recently, according to Fierce Pharma, unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-2 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diab……
The US Food and Drug Administration (FDA) announced on November 8, 2023 that Lilly's Zepbound injection was approved for long-term weight management of adults, which is applicable to obese or overweight adults (BMI i……
October 20, 2023 -- Bausch Health Companies Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxid……
October 28, 2023 -- Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on reshaping vision possibilities, today announced that the U.S. Food and Drug Administration (FDA) has approved QLOSI™ (p……
September 29, 2023 -- Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for LITFULO™ (ritlecitinib) to treat adults and adolescents 22 years of age and older wi……
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1
Tel: 025-82232955 025-82232966
Fax:025-82232933 025-82232944
E-mail: info@dorrapharma.com
